Oleg Astafurov becomes head of Alliance Healthcare Russia
This article was originally published in Scrip
Oleg Astafurov has become new director general of Alliance Healthcare Russia succeeding Igor Varlamov who led the company since 2007. Mr Astafurov was most recently head of Rigla, the retail arm of one of Russian largest pharmaceutical wholesalers, Protek; he had worked for Protek for more than 15 years. Alliance Healthcare Russia (formerly Apteka-Holding) is another of the country's largest pharmaceutical wholesalers; it had a turnover exceeding $1 billion in 2009. The company employs more than 2,000 people and has more than 40 divisions and trading offices across Russia.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.